Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers.

Breast cancer research and treatment - 1 Apr 2015

Laitman Yael, Keinan Boker Lital, Liphsitz Irena, Weissglas-Volkov Daphna, Litz-Philipsborn Shira, Schayek Hagit, Friedman Eitan

Abstract excerpt

Cancer risks and tumor types in male BRCA1 and BRCA2 mutation carriers are still unsettled. Cancer risks in men who were found to harbor a BRCA1 (n = 150) or a BRCA2 (n = 88) mutation or both (n = 2) were assessed by cross referencing with data on cancer occurrence in the Israeli National Cancer Registry. Incidence rates in mutation carriers were compared with men who were counseled, genotyped, and found not to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms, Male

Share to Germ-Line Mutation

Share to Incidence

Share to Israel

Share to Pancreatic Neoplasms

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 25788227
DOI: 10.1007/s10549-015-3340-4

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers.PMID 25788227Read ↗

Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.Semantic proximity Read ↗

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.Semantic proximity Read ↗

Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.Semantic proximity Read ↗

Genetic analyses of male breast cancer in Israel.Semantic proximity Read ↗

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.Semantic proximity Read ↗

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.Semantic proximity Read ↗

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.Semantic proximity Read ↗

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Hereditary breast cancer in Jews.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.